Becton, Dickinson and (BDX) PEG Ratio: History & Chart

Becton, Dickinson and Company (BDX)BDXBecton, Dickinson and Company

About Becton, Dickinson and Company

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

Franklin Lakes, NJ

72,000 employees

www.bd.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Thomas E. Polen Jr.

View full financials

BDX PEG Ratio Metrics

PEG RATIO

2.47

PEG RATIO AVG TTM

N/A

PEG RATIO AVG 3Y

0.97

PEG RATIO AVG 5Y

0.68

PEG RATIO AVG 10Y

3.25

PEG RATIO AVG 15Y

2.57

PEG RATIO AVG 20Y

0.92

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

+154.64%

CURRENT VS 5Y AVG

+265.02%

CURRENT VS 10Y AVG

-24.05%

CURRENT VS 15Y AVG

-3.72%

CURRENT VS 20Y AVG

+167.16%

SECTOR MEDIAN · HEALTHCARE

1.87

median of 49 covered companies

CURRENT VS SECTOR MEDIAN

+32.09%

vs the sector median at left

NAME	MARKET CAP	PEG RATIO	TTM	3Y	5Y
Becton, Dickinson and Company (BDX)	$60.26B	2.47	N/A	0.97	0.68
Cencora, Inc. (COR)vs ›	$62.18B	7.05	7.05	4.17	3.13
Cardinal Health, Inc. (CAH)vs ›	$54.46B	0.30	0.23	0.17	0.13
Boston Scientific Corporation (BSX)vs ›	$68.46B	0.88	2.57	1.84	2.46
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$71.62B	3.38	2.53	2.53	1.33
Edwards Lifesciences Corporation (EW)vs ›	$48.18B	6.43	0.05	5.11	4.08
Humana Inc. (HUM)vs ›	$46.67B	N/A	0.45	0.32	0.59
IDEXX Laboratories, Inc. (IDXX)vs ›	$44.93B	2.31	4.41	3.66	3.13
Cigna Corporation (CI)vs ›	$79.64B	0.15	0.15	0.28	0.23
IQVIA Holdings Inc. (IQV)vs ›	$40.61B	6.34	8.50	5.12	3.87

NAME

MARKET CAP

PEG RATIO

TTM

Becton, Dickinson and Company (BDX)

$60.26B

2.47

N/A

0.97

0.68

Cencora, Inc. (COR)vs ›

$62.18B

7.05

4.17

3.13

Cardinal Health, Inc. (CAH)vs ›

$54.46B

0.30

0.23

0.17

0.13

Boston Scientific Corporation (BSX)vs ›

$68.46B

0.88

2.57

1.84

2.46

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$71.62B

3.38

2.53

1.33

Edwards Lifesciences Corporation (EW)vs ›

$48.18B

6.43

0.05

5.11

4.08

Humana Inc. (HUM)vs ›

$46.67B

N/A

0.45

0.32

0.59

IDEXX Laboratories, Inc. (IDXX)vs ›

$44.93B

2.31

4.41

3.66

3.13

Cigna Corporation (CI)vs ›

$79.64B

0.15

0.28

0.23

IQVIA Holdings Inc. (IQV)vs ›

$40.61B

6.34

8.50

5.12

3.87

PEG Ratio FAQ

What is the PEG ratio for Becton, Dickinson and Company (BDX)?

The PEG ratio for BDX stock is 2.47.

Is Becton, Dickinson and Company's PEG ratio high or low?

The PEG ratio of 2.47 is 265% above its 5-year average of 0.68, near the high end of its 5-year range (0.09–2.47).

What is the 3Y average PEG ratio for Becton, Dickinson and Company (BDX)?

The 3Y average PEG ratio for BDX stock is 0.97.

What is the 5Y average PEG ratio for Becton, Dickinson and Company (BDX)?

The 5Y average PEG ratio for BDX stock is 0.68.

What is the 10Y average PEG ratio for Becton, Dickinson and Company (BDX)?

The 10Y average PEG ratio for BDX stock is 3.25.

What is the 15Y average PEG ratio for Becton, Dickinson and Company (BDX)?

The 15Y average PEG ratio for BDX stock is 2.57.

What is the 20Y average PEG ratio for Becton, Dickinson and Company (BDX)?

The 20Y average PEG ratio for BDX stock is 0.92.

DATE	PEG RATIO
2024-09-30	1.76
2021-09-30	0.18
2019-09-30	0.09
2017-09-30	13.34
2016-09-30	0.89
2013-09-30	0.62
2011-09-30	4.23
2010-09-30	1.04
2009-09-30	0.94
2008-09-30	0.49
2007-09-30	0.90
2006-09-30	3.01
2005-09-30	0.25
2003-09-30	0.83
2002-09-30	0.61
2001-09-30	27.97
2000-09-30	0.36
1999-09-30	1.44
1997-09-30	2.37
1996-09-30	1.23

DATE

PEG RATIO

2024-09-30

1.76

2021-09-30

0.18

2019-09-30

0.09

2017-09-30

13.34

2016-09-30

0.89

2013-09-30

0.62

2011-09-30

4.23

2010-09-30

1.04

2009-09-30

0.94

2008-09-30

0.49

2007-09-30

0.90

2006-09-30

3.01

2005-09-30

0.25

2003-09-30

0.83

2002-09-30

0.61

2001-09-30

27.97

2000-09-30

0.36

1999-09-30

1.44

1997-09-30

2.37

1996-09-30

1.23

PEG Ratio: 2.47

BDX PEG Ratio Chart

BDX Average PEG Ratio Chart

BDX Current vs Average PEG Ratio Chart

BDX PEG Ratio Metrics

BDX Competitors' PEG Ratio

Growth-Adjusted Valuation

PEG Ratio Formula & Definition

PEG Ratio FAQ

BDX PEG Ratio History

Related Metrics